What to Expect?
PharmaSynergyRx is known for creating a focused and tailored event that caters to companies pursuing co-development, partnerships, licensing, and commercial deals.
The event always goes beyond the ordinary, offering a comprehensive programme that includes Business Development-tuned content, opportunities for informal networking, and structured B2B meetings.
PharmaSynergyRx will bring together over 200 senior BD&L and C-suite executives from Europe, MENA, LATAM, and APAC regions. With a product focus exclusively on Prescription Medicines, the event ensures efficient partnering aligned with your business needs.
Now in its 8th year, PharmaSynergyRx has solidified its position as a premier Rx-focused partnering event for both global and regional companies.
Clear Product Portfolio Focus
- Primary, Niche, Branded, and Hybrid
- Generics, Value-Added Medicines (VAMs)
- Specialty, Biosimilars, and Hospital Products
- Legacy Products
- New Chemical Entities
- Technology Platforms: Dosage, Formulation, Delivery
1-2-1 Meetings & Networking
Networking and 1-2-1 meetings lie at the very core of our events.
As the event unfolds, you'll find the pre-scheduled time slots and content sessions seamlessly woven into the fabric of the day, ensuring that your agenda is personalised, leaving no room for missed opportunities.
Market Information & Presentations
We aim to provide diverse perspectives and strategic insights. In 2025, the event will feature compelling speakers discussing growth strategies, licensing, BD&L, portfolio approaches, and the evolving regional market landscape.
2025 Speaker Panel
Strategy and Growth
Daniel Vella Friggieri, Regional CEO – Europe & Middle East, Aspen Healthcare
Sundeep Dugar, President& CEO, Aayam Therapeutics
Rabbur Reza, Chief Operating Officer, Beximco Pharmaceuticals
Christian Fellowers, Investment Director, Inflexion Private Equity Partners
Thomas Christély, Chief Executive Officer, MetrioPharm
Navin Thadani, SVP Business Development, Aurobindo Pharma
Huaizheng Peng, Chief Business Officer, China Medical System Holdings
Anish Mehta, Chief Executive Officer, Synthon
Maha Mehanna, Vice President, Business Development & Portfolio, XGen Pharmaceuticals
Anthony Tennyson, Chief Executive Officer, Solvonis Therapeutics
Andrea Castellin, Chief Operating Officer, Brenta
Sej Brar, Partner, L.E.K. Consulting
Regulatory Perspectives
María de la Luz Lara Méndez, Chief Executive Officer, Udelá
Jon de Vlieger, Strategy Director, Lygature
Jack Wong, Founder of Asia Regulatory Professionals Association (ARPA), Adjunct Professor, Chinese University of Hong Kong, CEO, RNAscence
Partnering Platform
Our partnering platform serves as the launchpad, allowing you to plan and schedule meetings ahead of time. Whether you're seeking that crucial partnership, investment, or collaboration, this digital gateway empowers you to curate a lineup of meaningful interactions.
These are just some of the companies that have confirmed their participation
For the latest list of attendees, please contact yricci@lynx2market.com
Sponsor
Brenta develops micro and nanotechnology platforms for research and application in the fields of pharmaceutical science and materials. Brenta is therefore active in two business lines: one engaged in nanotechnology and theranostic applications to find solutions that improve the performance of active pharmaceutical ingredients with critical characteristics according to the biopharmaceutical classification system, the other instead focused on the development and production of innovative products with low environmental impact, both at B2B and B2C level.For more information, visit www.brenta.net/en/
Spotlight Companies
Venue
Leonardo Royal Hotel London City
8-14 Cooper's Row, London EC3N 2BQ, United Kingdom
www.leonardohotels.co.uk